191 related articles for article (PubMed ID: 24317198)
1. Acid sphingomyelinase determines melanoma progression and metastatic behaviour via the microphtalmia-associated transcription factor signalling pathway.
Bizzozero L; Cazzato D; Cervia D; Assi E; Simbari F; Pagni F; De Palma C; Monno A; Verdelli C; Querini PR; Russo V; Clementi E; Perrotta C
Cell Death Differ; 2014 Apr; 21(4):507-20. PubMed ID: 24317198
[TBL] [Abstract][Full Text] [Related]
2. Acid Sphingomyelinase Downregulation Enhances Mitochondrial Fusion and Promotes Oxidative Metabolism in a Mouse Model of Melanoma.
Coazzoli M; Napoli A; Roux-Biejat P; Palma C; Moscheni C; Catalani E; Zecchini S; Conte V; Giovarelli M; Caccia S; Procacci P; Cervia D; Clementi E; Perrotta C
Cells; 2020 Mar; 9(4):. PubMed ID: 32244541
[TBL] [Abstract][Full Text] [Related]
3. Essential role for acid sphingomyelinase-inhibited autophagy in melanoma response to cisplatin.
Cervia D; Assi E; De Palma C; Giovarelli M; Bizzozero L; Pambianco S; Di Renzo I; Zecchini S; Moscheni C; Vantaggiato C; Procacci P; Clementi E; Perrotta C
Oncotarget; 2016 May; 7(18):24995-5009. PubMed ID: 27107419
[TBL] [Abstract][Full Text] [Related]
4. Dasatinib Stimulates Its Own Mechanism of Resistance by Activating a CRTC3/MITF/Bcl-2 Pathway in Melanoma with Mutant or Amplified c-Kit.
Sabbah M; Krayem M; Najem A; Sales F; Miller W; Del Rincon S; Awada A; Ghanem GE; Journe F
Mol Cancer Res; 2021 Jul; 19(7):1221-1233. PubMed ID: 33741716
[TBL] [Abstract][Full Text] [Related]
5. Exploiting Honokiol-induced ER stress CHOP activation inhibits the growth and metastasis of melanoma by suppressing the MITF and β-catenin pathways.
Chiu CS; Tsai CH; Hsieh MS; Tsai SC; Jan YJ; Lin WY; Lai DW; Wu SM; Hsing HY; Arbiser JL; Sheu ML
Cancer Lett; 2019 Feb; 442():113-125. PubMed ID: 30391358
[TBL] [Abstract][Full Text] [Related]
6. Oncogenic BRAF regulates melanoma proliferation through the lineage specific factor MITF.
Wellbrock C; Rana S; Paterson H; Pickersgill H; Brummelkamp T; Marais R
PLoS One; 2008 Jul; 3(7):e2734. PubMed ID: 18628967
[TBL] [Abstract][Full Text] [Related]
7. β-Galactosylceramidase Promotes Melanoma Growth via Modulation of Ceramide Metabolism.
Belleri M; Paganini G; Coltrini D; Ronca R; Zizioli D; Corsini M; Barbieri A; Grillo E; Calza S; Bresciani R; Maiorano E; Mastropasqua MG; Annese T; Giacomini A; Ribatti D; Casas J; Levade T; Fabrias G; Presta M
Cancer Res; 2020 Nov; 80(22):5011-5023. PubMed ID: 32998995
[TBL] [Abstract][Full Text] [Related]
8. [The Importance of MITF Signaling Pathway in the Regulation of Proliferation and Invasiveness of Malignant Melanoma].
Urban P; Rabajdová M; Veliká B; Špaková I; Bolerázska B; Mareková M
Klin Onkol; 2016; 29(5):347-350. PubMed ID: 27739313
[TBL] [Abstract][Full Text] [Related]
9. GLI2 and M-MITF transcription factors control exclusive gene expression programs and inversely regulate invasion in human melanoma cells.
Javelaud D; Alexaki VI; Pierrat MJ; Hoek KS; Dennler S; Van Kempen L; Bertolotto C; Ballotti R; Saule S; Delmas V; Mauviel A
Pigment Cell Melanoma Res; 2011 Oct; 24(5):932-43. PubMed ID: 21801332
[TBL] [Abstract][Full Text] [Related]
10. Mitf regulation of Dia1 controls melanoma proliferation and invasiveness.
Carreira S; Goodall J; Denat L; Rodriguez M; Nuciforo P; Hoek KS; Testori A; Larue L; Goding CR
Genes Dev; 2006 Dec; 20(24):3426-39. PubMed ID: 17182868
[TBL] [Abstract][Full Text] [Related]
11. Mitf is the key molecular switch between mouse or human melanoma initiating cells and their differentiated progeny.
Cheli Y; Giuliano S; Botton T; Rocchi S; Hofman V; Hofman P; Bahadoran P; Bertolotto C; Ballotti R
Oncogene; 2011 May; 30(20):2307-18. PubMed ID: 21278797
[TBL] [Abstract][Full Text] [Related]
12. Role of microRNA-182 in posterior uveal melanoma: regulation of tumor development through MITF, BCL2 and cyclin D2.
Yan D; Dong XD; Chen X; Yao S; Wang L; Wang J; Wang C; Hu DN; Qu J; Tu L
PLoS One; 2012; 7(7):e40967. PubMed ID: 22848417
[TBL] [Abstract][Full Text] [Related]
13. Modulation of Acid Sphingomyelinase in Melanoma Reprogrammes the Tumour Immune Microenvironment.
Assi E; Cervia D; Bizzozero L; Capobianco A; Pambianco S; Morisi F; De Palma C; Moscheni C; Pellegrino P; Clementi E; Perrotta C
Mediators Inflamm; 2015; 2015():370482. PubMed ID: 26101462
[TBL] [Abstract][Full Text] [Related]
14. KIT
Phung B; Kazi JU; Lundby A; Bergsteinsdottir K; Sun J; Goding CR; Jönsson G; Olsen JV; Steingrímsson E; Rönnstrand L
Mol Cancer Res; 2017 Sep; 15(9):1265-1274. PubMed ID: 28584020
[TBL] [Abstract][Full Text] [Related]
15. G protein-coupled estrogen receptor enhances melanogenesis via cAMP-protein kinase (PKA) by upregulating microphthalmia-related transcription factor-tyrosinase in melanoma.
Sun M; Xie HF; Tang Y; Lin SQ; Li JM; Sun SN; Hu XL; Huang YX; Shi W; Jian D
J Steroid Biochem Mol Biol; 2017 Jan; 165(Pt B):236-246. PubMed ID: 27378491
[TBL] [Abstract][Full Text] [Related]
16. Role of β-catenin signaling in the anti-invasive effect of the omega-3 fatty acid DHA in human melanoma cells.
Serini S; Zinzi A; Ottes Vasconcelos R; Fasano E; Riillo MG; Celleno L; Trombino S; Cassano R; Calviello G
J Dermatol Sci; 2016 Nov; 84(2):149-159. PubMed ID: 27600927
[TBL] [Abstract][Full Text] [Related]
17. Overcoming MITF-conferred drug resistance through dual AURKA/MAPK targeting in human melanoma cells.
Pathria G; Garg B; Borgdorff V; Garg K; Wagner C; Superti-Furga G; Wagner SN
Cell Death Dis; 2016 Mar; 7(3):e2135. PubMed ID: 26962685
[TBL] [Abstract][Full Text] [Related]
18. MITF-independent pro-survival role of BRG1-containing SWI/SNF complex in melanoma cells.
Ondrušová L; Vachtenheim J; Réda J; Záková P; Benková K
PLoS One; 2013; 8(1):e54110. PubMed ID: 23349796
[TBL] [Abstract][Full Text] [Related]
19. Melanoma biomarker expression in melanocytic tumor progression: a tissue microarray study.
Nazarian RM; Prieto VG; Elder DE; Duncan LM
J Cutan Pathol; 2010 Apr; 37 Suppl 1():41-7. PubMed ID: 20482674
[TBL] [Abstract][Full Text] [Related]
20. Role of Acid Sphingomyelinase-Induced Signaling in Melanoma Cells for Hematogenous Tumor Metastasis.
Carpinteiro A; Beckmann N; Seitz A; Hessler G; Wilker B; Soddemann M; Helfrich I; Edelmann B; Gulbins E; Becker KA
Cell Physiol Biochem; 2016; 38(1):1-14. PubMed ID: 26741636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]